Form 8-K - Current report:
SEC Accession No. 0001213900-25-120129
Filing Date
2025-12-10
Accepted
2025-12-10 16:49:53
Documents
12
Period of Report
2025-12-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea026901601-8k_chinapharma.htm   iXBRL 8-K 26478
  Complete submission text file 0001213900-25-120129.txt   194337

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cphi-20251204.xsd EX-101.SCH 3047
3 XBRL LABEL FILE cphi-20251204_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE cphi-20251204_pre.xml EX-101.PRE 22380
14 EXTRACTED XBRL INSTANCE DOCUMENT ea026901601-8k_chinapharma_htm.xml XML 3782
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34471 | Film No.: 251562532
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)